2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow European Paediatric Soft Tissue Sarcoma Study Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma dactinomycin, carboplatin, cyclophosphamide - Sarcoma | Phase 3 | Unknown | European Paediatric Soft Tissue Sarcoma Study Group | 600 | 2006-06-01 | 2013-08-12 |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma doxorubicin hydrochloride, ifosfamide, adjuvant therapy - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 3 | Unknown | European Paediatric Soft Tissue Sarcoma Study Group | 250 | 2006-03-01 | 2013-08-12 |
Sarcoma (2) · Chondrosarcoma (1) · Dermatofibrosarcoma (1) · Fibrosarcoma (1) · Hemangiopericytoma, Malignant (1) · Hemangiosarcoma (1) · Liposarcoma (1) · Malignant mesenchymal tumor (1)
Doxorubicin (2) · Ifosfamide (2) · Radiotherapy (2) · Carboplatin (1) · Chemotherapy, Adjuvant (1) · Cyclophosphamide (1) · Dactinomycin (1) · Etoposide (1) · Neoadjuvant Therapy (1) · Topotecan (1) · Vincristine (1) · Vinorelbine (1)
Austria (2) · Belgium (2) · Denmark (2) · Ireland (2) · Spain (2) · Sweden (2) · Switzerland (2) · United Kingdom (2) · France (1)
Andrea Ferrari, MD (1) · Bernadette Brennan, MD (1) · Gianni Bisogno, MD (1) · Hans Merks, MD, PhD (1) · Joern Treuner, MD (1) · Max Van Noesel, MD, PhD (1) · Meriel Jenney, MD (1) · Modesto Carli, MD (1)